SCHEMBL12283494

SCHEMBL12283494

CC(C)COc1cccc(C=O)c1N1CCC[C@@H](NC(=O)OC(C)(C)C)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIM1 P11309 2/20 0.46
▸ PIM2 Q9P1W9 2/20 0.46
▸ KCNH2 Q12809 1/20 0.46
▸ MAP4K4 O95819 2/20 0.46
▸ BTK Q06187 4/20 0.43
▸ JAK3 P52333 2/20 0.43
▸ PIM3 Q86V86 1/20 0.42
▸ PDE10A Q9Y233 1/20 0.42
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ RET P07949 1/20 0.40
▸ KMT2A Q03164 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ USP30 Q70CQ3 2/20 0.39
▸ KIF18A Q8NI77 1/20 0.39
▸ DRD2 P14416 1/20 0.38
▸ EGFR P00533 1/20 0.38
▸ LCK P06239 1/20 0.38
▸ AURKA O14965 3/20 0.38
▸ PDPK1 O15530 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12283559 0.90 MAP4K4 (0.48) PIM1PIM2MAP4K4BTKJAK3
SCHEMBL12323317 0.88 MAP4K4 (0.46) PIM1PIM2MAP4K4BTKJAK3
SCHEMBL12322638 0.88 MAP4K4 (0.46) PIM1PIM2MAP4K4BTKJAK3
SCHEMBL12284337 0.88 MAP4K4 (0.46) PIM1PIM2MAP4K4BTKJAK3
SCHEMBL12284173 0.87 MAP4K4 (0.48) PIM1PIM2MAP4K4BTKJAK3
SCHEMBL12283763 0.87 MAP4K4 (0.46) PIM1PIM2MAP4K4BTKJAK3
SCHEMBL12322730 0.85 MAP4K4 (0.47) PIM1PIM2MAP4K4BTKJAK3
SCHEMBL2424606 0.85 PIM2 (0.69) PIM1PIM2KCNH2PIM3
SCHEMBL2424609 0.85 PIM2 (0.69) PIM1PIM2KCNH2PIM3
SCHEMBL2424601 0.85 PIM2 (0.69) PIM1PIM2KCNH2PIM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150051185-A1 Chemical Compounds 251 ASTRAZENECA AB (SE) 2015-02-19 — — US disclosed
US-20150051185-A1 Chemical Compounds 251 ASTRAZENECA AB (SE) 2015-02-19 — — US disclosed
US-8901307-B2 Chemical compounds 251 ASTRAZENECA AB (SE) 2014-12-02 — — US disclosed
US-8901307-B2 Chemical compounds 251 ASTRAZENECA AB (SE) 2014-12-02 — — US disclosed
US-20110218182-A1 CHEMICAL COMPOUNDS 251 ASTRAZENECA AB (SE) 2011-09-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110218182-A1 CHEMICAL COMPOUNDS 251 PIM1, PIM3, PIM2 PIM1 1/4885PIM2 3/4885KCNH2 2378/4885
US-20150051185-A1 Chemical Compounds 251 PIM1, PIM3, PIM2 PIM1 1/4885PIM2 3/4885KCNH2 2489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback